<p><span style="color: rgb(0,0,0);background-color: rgb(255,255,255);font-size: 16px;font-family: Arial;">The Fund aims to provide capital growth over the long term. The Fund invests at least 80% of its assets in shares (equities) and equity-related securities of companies, which are biotechnology or biotechnology-related, in any country. </span></p>


Janus Henderson Investors

Janus Henderson Investors UK Limited

Sector Equity Biotechnology

Morningstar Gbl Biotechnology NR USD

Equity

NASDAQ Biotechnology TR

Janus Henderson Hrzn Biotec A2 USD

Janus Henderson Hrzn Biotec E2 USD

2024

2023

2022

2021

2020

United States

United Kingdom

Denmark

France

Canada

Other countries

Unclassified

Healthcare

Vertex Pharmaceuticals Inc

Verona Pharma PLC ADR

argenx SE ADR

Amgen Inc

Soleno Therapeutics Inc

Ascendis Pharma AS ADR

BridgeBio Pharma Inc

Akero Therapeutics Inc

AstraZeneca PLC ADR

Avidity Biosciences Inc Ordinary Shares